Concepedia

Richard C. Kevin

RC

Statistics

Publications

47

Citations

2.8K

H-Index

30

Active since

2013

Affiliations

The University of Sydney(Current)

Macquarie University

UNSW Sydney

Stanford University

RTI International

Richard C. Kevin is an author at The University of Sydney specializing in cannabinoid pharmacology, pharmacology, and psychopharmacology.

ORCID

Publications per year

2013–2024

47

Publications

47

Pharmacology of Valinate and<i>tert</i>-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues

Samuel D. Banister, Mitchell Longworth, Richard C. Kevin et al. · ACS Chemical Neuroscience · 2016 · 247 citations

, , +13

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

Samuel D. Banister, Michael Moir, Jordyn Stuart et al. · ACS Chemical Neuroscience · 2015 · 241 citations

, , +12

Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135

Samuel D. Banister, Jordyn Stuart, Richard C. Kevin et al. · ACS Chemical Neuroscience · 2015 · 197 citations

, , +13

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition

Thomas R. Arkell, Nicholas Lintzeris, Richard C. Kevin et al. · Psychopharmacology · 2019 · 177 citations · Full text

, , +15

Effect of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol on Driving Performance

Thomas R. Arkell, Frederick Vinckenbosch, Richard C. Kevin et al. · JAMA · 2020 · 171 citations · Full text

, , +14

1–5 of 47